May 15 (Reuters)- Phoenixbio Co., Ltd. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 1.57 1.54 (+1.6 pct) (-10.1 pct) Operating 77 mln loss 267 mln Recurring 193 mln loss 292 mln Net 175 mln loss 507 mln EPS 43.07 yen loss 125.46 yen Ann Div NIL NIL NIL -Q2 Div NIL NIL NIL -Q4 Div NIL NIL NIL NOTE - Phoenixbio Co., Ltd.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T
